SCLERODERMA
Clinical trials for SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SCLERODERMA trials appear
Sign up with your email to follow new studies for SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA shot aims to calm stubborn autoimmune diseases
Disease control Not yet recruitingThis early-phase study tests a new drug called WGb-0301 for people with autoimmune diseases (like lupus or autoimmune hepatitis) that haven't responded to standard treatments. The drug uses mRNA technology to target and clear certain immune cells (B cells) that are causing the di…
Matched conditions: SCLERODERMA
Phase: EARLY_PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to catch silent lung threat in scleroderma
Diagnosis Not yet recruitingThis study will screen 35 adults with scleroderma for pulmonary hypertension using echocardiography. The goal is to see how often this serious lung condition occurs in these patients. The study is not yet recruiting.
Matched conditions: SCLERODERMA
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Scleroderma patients to decide: infographic vs. plain language for research results
Knowledge-focused Not yet recruitingThis study aims to find the best way to share research results with people who have scleroderma, a rare autoimmune disease. About 128 participants will be randomly assigned to receive either an infographic or a plain-language summary of a study. They will then rate how complete, …
Matched conditions: SCLERODERMA
Phase: NA • Sponsor: Lady Davis Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC